| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA996396030003316 |
|
|
Autore |
J. L. M <fl. 1696.> |
|
|
Titolo |
Cantique spirituel; et d'action de grace, sur l'horrible conspiration dont Dieu a delivré le Roy Guillaume [[electronic resource] ] : sur le chant des Commandemens / / par J.L.M |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
A Londres, : Se vend par C. Lucas, dans les Black-Fryers, auprès la riviere, 1696 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Soggetti |
|
Hymns, French |
Broadsides17th century.England |
Great Britain History William and Mary, 1689-1702 Early works to 1800 |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Caption title. |
Text in two columns; without music. |
Imperfect: creased with slight loss of text. |
Reproduction of original in: New York Public Library. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910828682803321 |
|
|
Autore |
Dorozhkin Sergey V. |
|
|
Titolo |
Calcium orthophosphate-based bioceramics and biocomposites / / Sergey V. Dorozhkin |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co., , 2016 |
|
©2016 |
|
|
|
|
|
|
|
|
|
ISBN |
|
3-527-69931-7 |
3-527-69930-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (504 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Biomedical materials - Testing |
Biomedical materials - Research |
Calcium phosphate - Biotechnology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Related Titles; Title Page; Copyright; Table of Contents; Preface; Part I: Calcium Orthophosphates (CaPO4): Occurrence, Properties, and Biomimetics; Chapter 1: Introduction; References; Chapter 2: Geological and Biological Occurrences; References; Chapter 3: The Members of CaPO4 Family; 3.1 MCPM; 3.2 MCPA (or MCP); 3.3 DCPD; 3.4 DCPA (or DCP); 3.5 OCP; 3.6 β-TCP; 3.7 α-TCP; 3.8 ACP; 3.9 CDHA (or Ca-def HA, or CDHAp); 3.10 HA (or HAp, or OHAp); 3.11 FA (or FAp); 3.12 OA (or OAp, or OXA); 3.13 TTCP (or TetCP); 3.14 Biphasic, Triphasic, and Multiphasic CaPO4 Formulations |
3.15 Ion-Substituted CaPO4References; Chapter 4: Biological Hard Tissues of CaPO4; 4.1 Bone; 4.2 Teeth; 4.3 Antlers; References; Chapter 5: Pathological Calcification of CaPO4; References; Chapter 6: Biomimetic Crystallization of CaPO4; References; Chapter 7: Conclusions and Outlook; References; Part II: Calcium Orthophosphate Bioceramics in Medicine; Chapter 8: Introduction; References; Chapter 9: General Knowledge and Definitions; References; Chapter 10: Bioceramics of CaPO4; 10.1 History; 10.2 Chemical Composition and Preparation; 10.3 Forming and Shaping; 10.4 Sintering and Firing |
ReferencesChapter 11: The Major Properties; 11.1 Mechanical |
|
|
|
|
|
|
|
|
|
|
Properties; 11.2 Electric/Dielectric and Piezoelectric Properties; 11.3 Possible Transparency; 11.4 Porosity; References; Chapter 12: Biomedical Applications; 12.1 Self-Setting (Self-Hardening) Formulations; 12.2 Coatings, Films, and Layers; 12.3 Functionally Graded Bioceramics; References; Chapter 13: Biological Properties and In Vivo Behavior; 13.1 Interactions with Surrounding Tissues and the Host Responses; 13.2 Osteoinduction; 13.3 Biodegradation; 13.4 Bioactivity; 13.5 Cellular Response; References |
Chapter 14: Nonbiomedical Applications of CaPO4References; Chapter 15: CaPO4 Bioceramics in Tissue Engineering; 15.1 Tissue Engineering; 15.2 Scaffolds and Their Properties; 15.3 Bioceramic Scaffolds from CaPO4; 15.4 A Clinical Experience; References; Chapter 16: Conclusions and Outlook; References; Part III: Biocomposites from Calcium Orthophosphates; Chapter 17: Introduction; References; Chapter 18: General Information and Knowledge; References; Chapter 19: The Major Constituents of Biocomposites and Hybrid Biomaterials for Bone Grafting; 19.1 CaPO4; 19.2 Polymers |
19.3 Inorganic Materials and CompoundsReferences; Chapter 20: Biocomposites and Hybrid Biomaterials Based on CaPO4; 20.1 Biocomposites with Polymers; 20.2 Self-Setting Formulations; 20.3 Formulations Based on Nanodimensional CaPO4 and Nanodimensional Biocomposites; 20.4 Biocomposites with Collagen; 20.5 Formulations with Other Bioorganic Compounds and/or Biological Macromolecules; 20.6 Injectable Bone Substitutes (IBSs); 20.7 Biocomposites with Glasses, Inorganic Compounds, Carbon, and Metals; 20.8 Functionally Graded Formulations; 20.9 Biosensors; References |
Chapter 21: Interaction among the Phases in CaPO4-Based Formulations |
|
|
|
|
|
| |